← Back to Search

Tele-rehabilitation for Lung Cancer

N/A
Waitlist Available
Research Sponsored by Kaiser Permanente
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, mid study (week 6), and end of study (week 12)
Awards & highlights

Study Summary

This trial will investigate the feasibility, acceptability, and safety of a tele-rehabilitation program for stage I-IIIA lung cancer survivors following curative intent therapy. The program will include inspiratory muscle training and behavioral support to promote walking. The primary outcome will be accelerometry-measured physical activity, and the secondary outcomes will be functional capacity, self-reported physical activity, control of dyspnea and anxiety symptoms, sleep quality, and quality of life.

Eligible Conditions
  • Lung Cancer

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, mid study (week 6), and end of study (week 12)
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, mid study (week 6), and end of study (week 12) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Difference in change in accelerometry-measured physical activity between baseline and week 12
Secondary outcome measures
Difference in change in anxiety symptoms between baseline and week 12
Difference in change in control of dyspnea between baseline and week 12
Difference in change in functional capacity between baseline and week 12
+3 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Tele-rehabilitationExperimental Treatment1 Intervention
Participants in the tele-rehabilitation arm will receive a home-based, remotely delivered rehabilitation program.
Group II: Education onlyActive Control1 Intervention
Participants in the education arm will receive educational materials only, delivered through telecommunication messages.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Tele-rehabilitation
2013
N/A
~230

Find a Location

Who is running the clinical trial?

Kaiser PermanenteLead Sponsor
538 Previous Clinical Trials
24,113,757 Total Patients Enrolled
American Lung AssociationOTHER
31 Previous Clinical Trials
10,942 Total Patients Enrolled

Media Library

Tele-rehabilitation Clinical Trial Eligibility Overview. Trial Name: NCT05059132 — N/A
Lung Cancer Research Study Groups: Tele-rehabilitation, Education only
Lung Cancer Clinical Trial 2023: Tele-rehabilitation Highlights & Side Effects. Trial Name: NCT05059132 — N/A
Tele-rehabilitation 2023 Treatment Timeline for Medical Study. Trial Name: NCT05059132 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are volunteers being accepted to participate in this research initiative?

"As per clinicaltrials.gov, recruitment for this study is still open; it was initially posted on 10th January 2022 and has been edited recently on 28th January 2022."

Answered by AI

How many participants are actively partaking in the experiment?

"Affirmative. The clinicaltrials.gov repository indicates that this research endeavor is currently seeking out volunteers, with the trial having been made available on January 10th 2022 and last edited on January 28th of the same year. 40 participants are needed from one medical facility."

Answered by AI

Who else is applying?

What state do they live in?
Virginia
How old are they?
65+
What site did they apply to?
Kaiser Permanente Colorado
What portion of applicants met pre-screening criteria?
Did not meet criteria
Recent research and studies
clinicaltrials.govStudy
Inspiratory Muscle Training and Behavioral Support to Alleviate Dyspnea and Promote Walking in Lung Cancer Survivors: A Pilot Study
2022. "Inspiratory Muscle Training and Behavioral Support to Alleviate Dyspnea and Promote Walking in Lung Cancer Survivors: A Pilot Study". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05059132.
~10 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top